definiens: and shall be deemed to mean t he * * * selected by Triangle or its Affiliates or sublicensees and reasonably ac ceptable to Dynavax . The * * * of the third party product and the Licensed Product shall be appropriately adjusted to account for any differences in potency based on the approved labeling of such third party product and the Licens ed Product . If Triangle is entitled to a royalty reduction based on unlicensed unit sales pursuant to Subsection 3.3(c ) for any royalty period, it or its Affiliates or sublicensees shall submit the * * *, as applicable, for the releva nt royalty period to Dynavax, together with Triangle 's or its Affiliates ' or subl icensees ' sales report for the relevant royalty period . Such sales reports for each royalty period in which Triangle is entitled to such royalty reduction shal l be submitted with the royalty report for such royalty period submitted pu rsuant to Section 4.1